Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 17 - 24 of 11616 results
Can a Consumer Plausibly Allege Your Product Labeling is False or Misleading Under California Law?
December 12, 2024| Blog| Viewpoint
Trump Taps David Sacks as AI and Crypto Czar — AI: The Washington Report
December 12, 2024| Article| Viewpoint
Appeals Court Overturns Nasdaq Requirement for Diversity on Boards
December 12, 2024| News
State Department Updates J-1 Skills List
December 11, 2024| Alert| Viewpoint
Six Critical Tips to Develop Disruptive Technology IP Strategies
December 10, 2024| News
New York Releases Paid Prenatal Leave Guidance Ahead of January Effective Date
December 9, 2024| Blog| Viewpoint
2024 Post-Election Analysis: Energy & Sustainability
December 6, 2024| Advisory| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.